QSimulate
About
QSimulate is a Cambridge-based quantum molecular simulation company founded in 2018 by Garnet Chan and Toru Shiozaki that develops cloud-based quantum chemical simulation tools for pharmaceutical, materials, and chemical companies.
November 2025: Raised new seed financing bringing total funding to over $11M, and launched QUELO v2.3, a quantum-powered simulation platform for drug discovery.
In August 2025, QSimulate partnered with Mitsui & Co. and Quantinuum to launch QIDO (Quantum-Integrated Discovery Orchestrator), a quantum-enabled chemistry platform integrating QSP Reaction software with Quantinuum's InQuanto platform. The QSP platform enables quantum chemical simulations modeling thousands of atoms with state-of-the-art quantum chemistry methods, enabling first-of-a-kind simulations of ligand-protein interactions throughout the computational drug discovery pipeline. Strategic partnerships include Japan Tobacco for small molecule drug discovery acceleration.
Categories
Key People
Garnet Chan (Co-founder), Toru Shiozaki (Co-founder)
Mentions on QuantumZeitgeist
Request Information
Interested in QSimulate? Get pricing, demos, or technical details.
Request Information
Get in touch with QSimulate about your project.
Claim This Profile
Are you from QSimulate? Verify your association to update your listing and receive notifications.
Claim Your Profile
Verify you represent QSimulate to update your listing.
Quick Facts
Links
Location
Loading map...
Stay Updated
Get the latest quantum computing news delivered to your inbox.